.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Farmers Insurance
Novartis
Federal Trade Commission
Deloitte
Julphar
Medtronic
US Army
Baxter
UBS
Teva

Generated: November 21, 2017

DrugPatentWatch Database Preview

Piramal Imaging Company Profile

« Back to Dashboard

What is the competitive landscape for PIRAMAL IMAGING, and when can generic versions of PIRAMAL IMAGING drugs launch?

PIRAMAL IMAGING has one approved drug.

There is one US patent protecting PIRAMAL IMAGING drugs.

There are thirty patent family members on PIRAMAL IMAGING drugs in twenty-five countries and fifteen supplementary protection certificates in twelve countries.

Summary for Piramal Imaging

International Patents:30
US Patents:1
Tradenames:1
Ingredients:1
NDAs:1
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Piramal Imaging
NEURACEQ
florbetaben f-18
SOLUTION;INTRAVENOUS204677-001Mar 19, 2014RXYesYes► Subscribe► SubscribeYY ► Subscribe
Piramal Imaging
NEURACEQ
florbetaben f-18
SOLUTION;INTRAVENOUS204677-001Mar 19, 2014RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Piramal Imaging

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
7,858,072Stilbene derivatives and their use for binding and imaging amyloid plaques► Subscribe
8,465,726Stilbene derivatives and their use for binding and imaging amyloid plaques► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Piramal Imaging Drugs

Country Document Number Estimated Expiration
HungaryS1500014► Subscribe
Denmark2213652► Subscribe
Norway20073650► Subscribe
Ukraine91996► Subscribe
Costa Rica9206► Subscribe
Netherlands300719► Subscribe
Japan2008524243► Subscribe
Eurasian Patent Organization012334► Subscribe
European Patent Office1841465► Subscribe
New Zealand555942► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Supplementary Protection Certificates for Piramal Imaging Drugs

Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
90005-3Sweden► SubscribePRODUCT NAME: FLORBETABEN (18F); REG. NO/DATE: EU/1/13/906 20140224
00719Netherlands► SubscribePRODUCT NAME: FLORBETABEN (18F); REGISTRATION NO/DATE: EU/1/13/906 20140220
2015 00018Denmark► SubscribePRODUCT NAME: FLORBETABEN (18F); REG. NO/DATE: EU/1/13/906/001 20140224
647Luxembourg► SubscribePRODUCT NAME: FLORBETABEN (18F). FIRST REGISTRATION: 20140224
2015000018Germany► SubscribePRODUCT NAME: FLORBETABEN (18F); REGISTRATION NO/DATE: EU/1/13/906/001 20140220
1 2-2015Slovakia► SubscribePRODUCT NAME: FLORBETABEN (18F); REGISTRATION NO/DATE: EU/1/13/906/001 20140224
15/008Ireland► SubscribePRODUCT NAME: FLORBETABEN (18F); REGISTRATION NO/DATE: EU/1/13/906/001 20140220
0150010 00142Estonia► SubscribePRODUCT NAME: FLORBETABEEN (18F);REG NO/DATE: EU/1/13/906 24.02.2014
2015005Lithuania► SubscribePRODUCT NAME: FLORBETABENUM (18F); REGISTRATION NO/DATE: EU/1/13/906/001 20140220
4Finland► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Argus Health
Healthtrust
Fuji
Medtronic
Covington
Farmers Insurance
Harvard Business School
Johnson and Johnson
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot